Respiratory Medicine
Volume 104, Issue 3 , Pages 356-361 , March 2010

Comparison of doctor and patient assessments of asthma control

Received 14 April 2009 ,Accepted 14 October 2009.

References 

  1. ISAAC Steering Committee . Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema. ISAAC. Lancet. 1998;351:1225–1232
  2. National Asthma Education and Prevention Programme Guideline Committee . Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. Atlanta: US Department of Health and Human Sciences. National Institute of Health; August 2007;
  3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Workshop Report; 2006. http://www.ginasthma.com (accessed 12 December 2007).
  4. Lenney W, Wells NEJ, O'Neill BA. The burden of paediatric asthma. Eur Respir J. 1994;4:49–62
  5. Rabe KF, Vermiere PA, Soriono JB, Maier WX. Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study. Eur Respir J. 2001;16(5):802–807
  6. Lai CK, De Guia TS, Kim YY, et al. Asthma control in the Asia–Pacific region: the asthma insights and reality in Asia–Pacific study. J Allergy Clin Immunol. 2003;111:263–268
  7. Adachi M, Morikawa A, Ishihara K. Asthma insights and reality in Japan. Arerugi. 2002;51:411–420
  8. Asthma in America. http://www.asthmainamerica.com; 2002 (accessed 15 May 2008).
  9. Green RJ, Davis G, Price D. Perceptions, impact and management of asthma in South Africa: a patient questionnaire study. Prim Care Respir J. 2008;17:212–216
  10. Rabe KF, Mitsuru A, Lai CKW, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–47
  11. Lundback B, Dahl R. Assessment of asthma control and its impact on optimal treatment strategy. Allergy. 2007;62(6):611–619
  12. Szefler SJ. Challenges in assessing outcomes for pediatric asthma. J Allergy Clin Immunol. 2001;107(5 Suppl.):S456–464
  13. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008;31:320–325
  14. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65
  15. Juniper EF, Bousquet J, Abetz L, Bateman ED, The GOAL Committee . Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the asthma control questionnaire. Respir Med. 2006;100:616–621
  16. SPSS® for WindowsTM, release 6.1.3. IL, USA: Michigan; 1995;
  17. Vermiere P. Asthma control and differences in management practices across seven European countries. Respir Med. 2005;96:142–149
  18. Vollmer WM, Markson LE, O'connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization. A prospective evaluation. Am J Respir Crit Care Med. 2003;165:195–199
  19. Lundbäck B, Rönmark E, Lindberg A, Jonsson A, Larsson L, Pétavy F, et al. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med. 2006;100:2–10
  20. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martínez-Jimenez NE, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007;61(5):725–736
  21. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/Formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171:129–136
  22. Krishnan JA, Diette GB, Skinner EA, Clark BD, Steinwachs D, Wu AW. Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Arch Intern Med. 2001;161:1660–1668

PII: S0954-6111(09)00331-X

doi: 10.1016/j.rmed.2009.10.010

Respiratory Medicine
Volume 104, Issue 3 , Pages 356-361 , March 2010

Article Tools